Spine Oncology Registry for Patients with Spine Tumors
This is an observational study, meaning it collects information about patients who are already receiving a specific treatment, rather than testing a new one. It's for adults (18 years or older) with primary or metastatic (spread from another part of the body) spine tumors who have surgery to decompress and stabilize the spine, followed by radiation therapy. The study aims to understand how well patients do after this treatment, looking at how long they live (overall survival) and if the tumor stays controlled in the treated area (local control). Researchers will also track how long patients live without their disease getting worse (progression-free survival). The study plans to include about 3000 participants. The current recruitment status is unclear.
- Study design
- This is an observational study, not testing a new intervention, and plans to enroll 3000 participants. It collects information from patients undergoing a specific treatment sequence.
- What's involved
- You will be asked to complete some patient-reported outcome questionnaires. Researchers will also collect information from your medical records.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your overall survival will be measured at 12, 18, and 24 months. Local control and progression-free survival will be measured at various time points up to 24 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Spine Oncology Registry
At a glance
Conditions
Where it's being run
5 sites across 5 statesStudy leadership
- James B Elder, MD · PRINCIPAL_INVESTIGATOR · Ohio State University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Overall survival12, 18, 24 months
- Local control of treated lesion based on radiographic review3, 6, 9, 12, 15, 16, 21, 24 months
Patients will be classified as achieving local control if demonstrating response of treated spine lesion after treatment. Local control will be assessed by comparing the radiographic images after treatment and prospectively every 3 months for up to 24 months
- Progression free survival3, 6, 9, 12, 15, 16, 21, 24 months